Overview

HarborSite, a Harvard/Wyss Institute spinoff, is pioneering a safe and efficient gene insertion technology to provide curative treatments for rare genetic and common disorders. By engineering compact, simple yet potent enzymes — recombinases — HarborSite can efficiently and precisely integrate large DNA cargos into genomic safe harbors for robust and durable therapeutic gene expression, with an initial focus on liver and blood cell editing.